✦ LIBER ✦

Risk of Peptic Ulcer Hospitalizations in Users of NSAIDs With Gastroprotective Cotherapy Versus Coxibs

✍ Scribed by Wayne A. Ray; Cecilia P. Chung; C. Michael Stein; Walter E. Smalley; Kathi Hall; Patrick G. Arbogast; Marie R. Griffin

Book ID: 119759964
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 577 KB
Volume: 133
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2007.06.058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CagA Positive Helicobacter Pylori Strain

CagA Positive Helicobacter Pylori Strains Are Associated with Increased Risk of Peptic Ulcer Bleeding Among NSAID Users. A Multicenter Case-Control Study

✍ Michalis Economou; Dimitrios Tzourmakliotis; Spilios Manolakopoulos; Sotiris Bet 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Su1772 Potentially Reversible Risk Facto

Su1772 Potentially Reversible Risk Factors for Peptic Ulcer Bleeding in Average-Risk Users of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Low-Dose Aspirin (ASA)

✍ Ho, Charita W.; Tse, Yee Kit; Ching, Jessica; Kee, Carmen; Cheong, Pui Kwan; Cha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Eradication of H. Pylori versus maintena

Eradication of H. Pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: A prospective randomizd study

✍ FKL Chan; JY Sung; R Suen; YT Lee; WK Leung; VKS Leung; JCY Wu; SCS Chung 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Tu1553 Irsogladine, a Gastroprotective D

Tu1553 Irsogladine, a Gastroprotective Drug, Protects Against NSAID-Induced Esophagitis, Peptic Ulcers, and Small Intestinal Mucosal Damages in Healthy Subjects: A Prospective Randomised Study of Comparison With Omeprazole

✍ Kuramoto, Takanori; Umegaki, Eiji; Kojima, Yuichi; Narabayashi, Ken; Nouda, Sada 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Randomized controlled trial of standard

Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding

✍ W. H. Chan; L. W. Khin; Y. F. A. Chung; Y. C. Goh; H. S. Ong; W. K. Wong 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## Background Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate (pri

PGS9: THE COST-EFFECTIVENESS OF HIGH DOS

PGS9: THE COST-EFFECTIVENESS OF HIGH DOSE ORAL VERSUS INTRAVENOUS PROTON PUMP INHIBITION IN HIGH-RISK PATIENTS WITH BLEEDING PEPTIC ULCERS HAVING UNDERGONE THERAPEUTIC ENDOSCOPY

✍ A Barkun; V Adam; WA Kennedy; CA Fallone; K Herba; M Bardou 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB